Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
9.86
-0.13 (-1.30%)
May 14, 2025, 9:49 AM - Market open

Rapport Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
57.656.8170.1731.16
Short-Term Investments
227.78248.4877.31-
Cash & Short-Term Investments
285.38305.28147.4831.16
Cash Growth
47.68%107.00%373.31%-
Prepaid Expenses
0.10.31.50.11
Restricted Cash
0.110.110.09-
Other Current Assets
5.384.121.81-
Total Current Assets
290.97309.8150.8731.27
Property, Plant & Equipment
10.874.9740.34
Long-Term Deferred Charges
--0.3-
Other Long-Term Assets
0.210.160.25-
Total Assets
302.05314.93155.4231.6
Accounts Payable
2.141.952.51.45
Accrued Expenses
6.246.085.630.21
Current Portion of Leases
1.010.740.67-
Total Current Liabilities
9.388.778.81.66
Long-Term Debt
--4.210.44
Long-Term Leases
6.830.741.48-
Total Liabilities
16.229.5114.4812.1
Common Stock
0.040.0400.03
Additional Paid-In Capital
433.7429.6619.80.56
Retained Earnings
-147.81-123.75-45.44-10.65
Comprehensive Income & Other
-0.1-0.520-
Total Common Equity
285.84305.43-25.63-10.06
Shareholders' Equity
285.84305.43140.9419.51
Total Liabilities & Equity
302.05314.93155.4231.6
Total Debt
7.841.486.3510.44
Net Cash (Debt)
277.54303.8141.1320.72
Net Cash Growth
45.11%115.26%581.01%-
Net Cash Per Share
9.5614.6593.7326.66
Filing Date Shares Outstanding
36.536.54.170.78
Total Common Shares Outstanding
36.536.584.170.78
Working Capital
281.59301.04142.0729.61
Book Value Per Share
7.838.35-6.15-12.95
Tangible Book Value
285.84305.43-25.63-10.06
Tangible Book Value Per Share
7.838.35-6.15-12.95
Machinery
4.333.781.760.3
Construction In Progress
-0.430.030.06
Leasehold Improvements
0.280.280.26-
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q